← Research library

Investigation of the actoprotective properties of the tripeptide Pinealon

Animal research · 2015

What was studied
24 five-month-old male outbred rats (250–300 g), four groups; three treadmill groups and one vivarium control
Main finding
Treadmill time improved in all training arms. The authors report day-10 increases of 18 minutes with Pinealon and 13.8 minutes with Metaprot relative to their own baselines.

Pinealon · treadmill time · Day 3 +8.7 min; day 5 +13.2 min; day 10 +18 min · Reported as 175%, 214% and 254% of its baseline, respectively. The paper reports persistence for three days after stopping.

Related evidence maps: Sports performance ↗

Reported findings and study design

24 male rats; vivarium control, trained control, Metaprot and Pinealon. Daily treadmill to exhaustion.

Population or model 24 five-month-old male outbred rats (250–300 g), four groups; three treadmill groups and one vivarium control

Dose, route and schedule

Pinealon T-33 75 µg/kg or Metaprot 25 mg/kg intraperitoneally, 10 treatment days with a 2-day interval after day 5. Daily treadmill testing at 35 m/min; trained control received no drug.

Protocol source ↗ · Original publisher PDF methods

Results · Full original PDF, treadmill results narrative and Table 1
MeasureResultComparison, timing and statistics
Pinealon · treadmill timeDay 3 +8.7 min; day 5 +13.2 min; day 10 +18 minReported as 175%, 214% and 254% of its baseline, respectively. The paper reports persistence for three days after stopping.
Metaprot · treadmill timeDay 5 +8.4 min; day 10 +13.8 minWithin-arm baseline comparisons. The authors report a decline to about 10 min on day 11 after cessation.
Training effectAll three treadmill groups improved during trainingThe paper attributes some early improvement to training. Baseline-relative changes do not establish a between-drug effect.
Pinealon · hemoglobin158.2±8.8 → 128.6±4.3 g/LBaseline to day 10; marked p≤0.01 versus own baseline. Trained control: 137.0±3.8 → 158.0±8.2 g/L.
Pinealon · erythrocytes8.8±0.6 → 7.0±0.5 million/µLBaseline to day 10; marked p≤0.05 versus own baseline. The decrease is a separate finding, not established as beneficial.
Table 1 · selected hematology values (M±m)
Table 1 · selected hematology values (M±m)
Group, measureBaselineDay 5Day 10
Pinealon · leukocytes (thousands/µL)14.6±1.28.4±1.2**10.2±1.3*
Pinealon · erythrocytes (millions/µL)8.8±0.68.4±0.37.0±0.5*
Pinealon · hemoglobin (g/L)158.2±8.8144.7±7.0128.6±4.3**
Pinealon · platelets (thousands/µL)847±103789±111575±120
Trained control · hemoglobin (g/L)137.0±3.8142.0±8.5158.0±8.2**
Metaprot · hemoglobin (g/L)166.8±11.7139.2±12.6150.8±8.4

* p≤0.05; ** p≤0.01 relative to each group’s own baseline. No between-arm statistical test inferred.

The treadmill study documents an animal training experiment. Different starting values, small groups and mixed hematology limit any comparative performance claim.

Source for these results ↗ · Reviewed 2026-11-08

Study limitations and source details

Study limitations

  • Animal endurance is not human cognitive performance, sleep, or occupational safety.
  • No numerical effect estimate is entered before table-level review.
  • The original PDF identifies issue 2(38); some later bibliographies give conflicting issue numbers.

Source details

Original 7-page PDF, methods, treadmill narrative and selected hematology values checked.

Sources checked

Citation

Animal / experimentalFull text available

G. S. Belyaeva, O. K. Davydova, A. I. Erofeev, V. A. Maydan, G. A. Ryzhak, T. V. Siretskaya, V. Kh. Khavinson. Investigation of the actoprotective properties of the tripeptide Pinealon Biotekhnosfera. 2(38):25–31

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards